AstraZeneca jab benefits ‘outweigh risks’ but under-30s offered alternative

Published on April 7, 2021 - Duration: 01:13s

AstraZeneca jab benefits ‘outweigh risks’ but under-30s offered alternative

The benefits of the AstraZeneca vaccine outweigh the risks for the “vast majority” of people after cases of blood clots were detected in an “extremely small” number of people, Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency said.


You are here


💡 newsR Knowledge: Other News Mentions

AstraZeneca

British pharmaceutical company
The drugmaker AstraZeneca (AZ) promised this morning to raise its annual dividend by 7% this year.
Credit: Sky News - Published 5 days ago

Related news from verified sources

The EU's medicines regulator said on Wednesday that blood clots should be listed as a rare side effect of the AstraZeneca vaccine but the benefits of the jab...
on April 7, 2021 • IndiaTimes

Mexico's president said on Thursday he now plans to get the AstraZeneca coronavirus vaccine to boost confidence in the shot after it was linked to a rare...
on April 8, 2021 • IndiaTimes

Related videos from verified sources

Should I be worried about the AstraZeneca Covid-19 vaccine? 01:40
Video credit: PA - Press Association STUDIO - Published on April 7, 2021 

EMA: Benefits of AstraZeneca jab outweigh risks 01:35
Video credit: PA - Press Association STUDIO - Published on April 7, 2021 

UK regulator says AstraZeneca vaccine safe despite 7 clot deaths 01:00
Video credit: Euronews English - Published on April 3, 2021 

You might like